J.Henderson Gl.Life Sciences F.A2/  IE0009355771  /

Fonds
NAV11/27/2023 Chg.-0.2200 Type of yield Investment Focus Investment company
46.3200USD -0.47% reinvestment Equity Worldwide Janus Henderson Inv. 
 

Investment goal

The Fund seeks long - term growth of capital by investing primarily in life - science equity securities of companies located anywhere in the world and selected for their growth potential.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Health / Pharma
Benchmark: MSCI World Healthcare Index
Business year start: 1/1
Last Distribution: -
Depository bank: J.P. Morgan SE
Fund domicile: Ireland
Distribution permission: Austria, Germany, Switzerland, United Kingdom
Fund manager: Andy Acker, Daniel Lyons
Fund volume: 3.44 bill.  USD
Launch date: 3/31/2000
Investment focus: -

Conditions

Issue surcharge: 5.00%
Max. Administration Fee: 1.50%
Minimum investment: 2,500.00 USD
Deposit fees: -
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Janus Henderson Inv.
Address: 201 Bishopsgate, EC2M 3AE, London
Country: United Kingdom
Internet: www.janushenderson.com/
 

Assets

Stocks
 
99.69%
Cash
 
0.30%
Others
 
0.01%

Countries

United States of America
 
70.93%
Denmark
 
5.56%
United Kingdom
 
4.78%
Switzerland
 
4.10%
France
 
2.79%
Ireland
 
2.26%
Netherlands
 
1.71%
Japan
 
1.61%
China
 
1.21%
Virgin Islands (British)
 
0.78%
Germany
 
0.68%
Cash
 
0.30%
Bermuda
 
0.25%
Cayman Islands
 
0.23%
Others
 
2.81%

Branches

Pharma/Biotechnology
 
58.81%
Healthcare services
 
19.56%
Healthcare appliances
 
17.03%
Parma, wholesale
 
1.49%
Cash
 
0.30%
Others
 
2.81%